<DOC>
	<DOCNO>NCT02005614</DOCNO>
	<brief_summary>The purpose study collect prospective data use comparator future subsequent study attempt increase efficacy reduce toxicity gamma knife radiosurgery .</brief_summary>
	<brief_title>A Pilot/Phase II Study Gamma Knife Radiosurgery Brain Metastases Using 3Tesla MRI Rational Dose Selection</brief_title>
	<detailed_description>The aim study pilot study measure local control `` rational dose '' select gamma knife radiosurgery brain metastasis measure treatment related toxicity rational dose select gamma knife radiosurgery brain metastasis . In addition , quality life neurocognition patient undergo gamma knife radiosurgery measure use validate European Organisation Research Treatment Cancer QLQ-C30 QLQ-BN20 survey instrument . `` Rational dose selection '' concept wherein dos use stereotactic radiosurgery select base tumor volume , prior irradiation whole brain radiotherapy , relative radioresistance tumor ( radioresistant = melanoma , renal cell carcinoma , sarcoma ; radiosensitive = breast cancer , lung cancer , colorectal cancer , gastrointestinal cancer ) . Eligible patient histologically confirm cancer MRI evidence metastatic disease within brain . Patients eligible trial intracranial radiosurgery recommend treatment brain metastasis . Patients exclude extremely radiosensitive tumor ( leukemia , lymphoma ) , radiosensitivity syndrome , resection brain metastasis , tolerate MRI placement stereotactic head frame . All patient must sign informed consent . Radiation consist gamma knife radiosurgery deliver use dos select base concept `` rational dose selection '' summarize .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Carcinoma , Renal Cell</mesh_term>
	<mesh_term>Brain Neoplasms</mesh_term>
	<mesh_term>Gastrointestinal Neoplasms</mesh_term>
	<criteria>Patients must histologically cytologically confirm malignancy ( leukemia lymphoma ) . There must metastatic brain disease apparent magnetic resonance image offer medical indication brain radiation . Age &gt; 18 Karnofsky Performance Status &gt; 70 MRI perform within 4 week trial enrollment Medical oncologist consent physician verifies chemotherapy option exist treatment intracranial therapy , chemotherapy plan initiate completion radiation . Or , survival estimate medical oncologist enrol physician &gt; 3 month . Extremely radiosensitive tumor ( lymphoma , leukemia ) Radiosensitivity syndrome ( scleroderma , dermatomyositis , genetic syndrome predisposes adverse radiotherapy complication ) Evidence leptomeningeal dissemination Resection brain metastasis , otherwise untreated radiation brain lesion ( present postoperative consolidative radiotherapy ) Presence medical device ( pacemaker , stent ) allergy precludes contrast enhance MRI Patient unable tolerate placement stereotactic headframe Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Rational dose selection</keyword>
	<keyword>gamma knife radiosurgery</keyword>
</DOC>